CPIX

Announcements

Nothing here yet

Daily updates

• Cumberland postponed long-term Phase 2 FIGHT DMD extension results for ifetrobanSep 1, 2026

FDA designations

Nothing here yet

News

• Cumberland Pharmaceuticals launched VIBATIV in ChinaMay 29, 2026
• Cumberland Pharmaceuticals received FDA Fast Track designation for its Ifetroban program in Duchenne muscular dystrophyFeb 5, 2026
• CALDOLOR® (ibuprofen) injection CMS J-code now associated with reimbursement price supporting non-opioid pain managementDec 8, 2025
• Cumberland Pharmaceuticals announces product approval in MexicoOct 2, 2025